Evidence map›Paper›PMID 20102759›Full record

ArticleGastroenterology2010

miRNA delivery: emerging therapy for hepatocellular carcinoma.

Sara Toffanin, Augusto Villanueva, Josep M Llovet

Abstract readComment
PubMed Publisher
In one paragraph

Article in Gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. miR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  4. Integration of genomic information in the clinical management of HCC.Best practice & research. Clinical gastroenterology · 2014
    Review
  5. Article
  6. Article
  7. New strategies in hepatocellular carcinoma: genomic prognostic markers.Clinical cancer research : an official journal of the American Association for Cancer Research · 2010
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sara ToffaninMount Sinai Liver Cancer Program, Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York, USA.
Augusto Villanueva
Josep M Llovet

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID20102759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.